Certara

PRESS RELEASE

Brazilian health surveillance agency, ANVISA, adopts Certara’s Phoenix software

Certara, a provider of software for model-informed drug development and regulatory science, today announced that the Brazilian National Health Surveillance Agency – ANVISA (Agência Nacional de Vigilância Sanitária) – is now also employing Certara’s Phoenix WinNonlin software for reviewing drug regulatory submissions

PRESS RELEASE

Certara Acquires d3 Medicine

Certara, a provider of decision support technology and consulting services to optimise drug development and improve health outcomes, has announced that it has acquired d3 Medicine. d3 Medicine, which is based in Parsippany, NJ, and Melbourne, Australia, provides strategic planning and stewardship of complex drug development programs.

Pages

Feature

David Wang gives his view on how modern laboratories can leverage data to provide maximum value

Feature

Elsevier’s Jabe Wilson predicts radical changes in the ways AI will be used in scholarly communications

Feature

Robert Roe looks at advances in automotive simulation

Feature

Sophia Ktori reveals the informatics company’s history – and plans for the future

Feature

Robert Roe reports from the SC17 conference keynote, detailing progress on the Square kilometre Array project